Insulin aspart (Biogenomics)

N/A

Report date: 2025/02/19 16:42:49

Base Information

Drug NameInsulin aspart (Biogenomics)
Drug Alias NameRapid acting insulin analogueNovorapid biosimilarINSUQUICK
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsDiabetes Mellitus
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2023/11/01
Country/TerritoryIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBiogenomicsUSV Pvt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesUSV Pvt LtdBiogenomics
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A